{"id":812557,"date":"2025-02-13T06:04:15","date_gmt":"2025-02-13T11:04:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/"},"modified":"2025-02-13T06:04:15","modified_gmt":"2025-02-13T11:04:15","slug":"zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/","title":{"rendered":"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">VANCOUVER, British Columbia, Feb.  13, 2025  (GLOBE NEWSWIRE) &#8212; Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will report its fourth quarter and full year 2024 financial results after market close on March 5, 2025. Following the announcement, management will host a conference call and webcast to discuss financial results and provide a corporate update on\u00a0March 5, 2025 at\u00a04:30 pm Eastern Time (ET).<\/p>\n<p>The event will be webcast live with dial-in details and webcast replays available on Zymeworks\u2019 website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rLixcza9gfxGYvUPEzi6JXk1QImfp-6IpGE0xkcODpC-aWToyJispB2YJgCh55w7zspiy2zLNXVNkj18mLoIRwor3zR_1MtCsILpJo0Z_noucsjSkqAptSr6JJ1CobR21UJ7omeNd_m0luyG7tHPabkQVhzS6iBhuzTpUNEd4CQ=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.zymeworks.com\/events-and-presentations<\/a><\/p>\n<p>\n        <strong>About Zymeworks Inc. <\/strong>\n      <\/p>\n<p>Zymeworks\u00a0is a global clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks\u2019 mission is to make a meaningful difference in the lives of people impacted by difficult-to-treat conditions such as cancer, inflammation, and autoimmune disease. The Company\u2019s complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates.\u00a0Zymeworks\u00a0engineered and developed zanidatamab, a HER2-targeted bispecific antibody using the Company\u2019s proprietary Azymetric\u2122 technology.\u00a0Zymeworks\u00a0has entered into separate agreements with BeiGene, Ltd. (BeiGene) and\u00a0Jazz Pharmaceuticals Ireland Limited\u00a0(Jazz Pharmaceuticals), granting each exclusive rights to develop and commercialize zanidatamab in different territories. The\u00a0U.S.\u00a0FDA granted accelerated approval of Ziihera<sup>\u00ae\u00a0<\/sup>(zanidatamab-hrii) 50mg\/mL for injection for intravenous use for the treatment of adults with previously-treated, unresectable or metastatic HER2-positive (IHC 3+) second-line biliary tract cancer (BTC). Ziihera<sup>\u00ae<\/sup>\u00a0is the first and only dual HER2-targeted bispecific antibody approved for HER2-positive BTC in the\u00a0U.S. Zanidatamab is currently under regulatory review in the EU and China for second-line BTC and is being evaluated in multiple global clinical trials as a potential best-in-class treatment for patients with multiple HER2-expressing cancers. Zymeworks\u00a0is rapidly advancing a robust pipeline of wholly-owned product candidates, leveraging its expertise in both antibody-drug conjugates and multispecific antibody therapeutics targeting novel pathways in areas of significant unmet medical need. Phase 1 studies for ZW171 and ZW191 are now actively recruiting with investigational new drug applications for ZW220 and ZW251 planned for 2025. In addition to Zymeworks\u2019 pipeline, its therapeutic platforms have been further leveraged through strategic partnerships with global biopharmaceutical companies. For information about\u00a0Zymeworks, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QuT1yWJsYY4WHlVURnDCWn8ja4rVJID1EqxchJtUuxqb9nTGNdwql3CtsTuTvxUD3cpWYxmKzkzaPNRbPV6zBrFC3D_qafdREMxNgbPwhOZZl_YpuPURG4foGctTX47Vo5QJyMrf28BVUmU4WXmc_RPwnSmgJs4tV50cDIP9UkLzOpzbt3XdkYL6rJ7xJBkct11EXkPet36_qkEwM37SVIVj49QXHbMOkxn4lucaXJ5IrWPC7eDKPJenY0_g6p1-_nmDIWFcaElltztU8V1NEBk4xr7PnejolB-pvRGd1twSiBc7FOrjkZ-KKa1I3qhuTpEN8ULPrpT1c-EwZCUiBCoK4cCzIeRSS9ijY1JEzYUXd61RuksA9kJD86rVqpGDvti9SV6lzkoiPTNY1mrKEev9exOyakqqzAMsWKkKTTs2p5F8SDq7P3nv6k9LVMocoQzR1a3ryBZ4PsSyDGfLnMmubqqS5S7XbO6nAScXLDg=\" rel=\"nofollow\" target=\"_blank\">www.zymeworks.com<\/a>\u00a0and follow\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DWDRNKB_6M7HeUMzJ-rhPiixZottqDx3g4DV9U6t01JAHaYtnW0mTbvThQGcHKzdyV8y9ZKrTCAuLPCxGhp2ewYpewlg4AoSnw6HCQcZkzSZq3-DE0HmnDkeH_Vc70YfghD2gXRjB2mvG1KuHd8ha3DCJYCoCX5KOzPzTeGjRLjkfAcD4mtvOKKs4QtKeJumrjFqIdktvuUtUzlR65kvZOW1hUbKKgg7lpga3nWnlJp2tlMSpctuAH6bN-pxXTwGy2CcDT6EJ5qsN5MOy50y2erWrGvT4A79vzjPQC3zHZAW2z_TbR4qYfpzUjSGG--TxRZELthVG-4ov8cpwttD6v65yj95c0KwOTA4H4PoMzj24i91CU7I4Xu75va7XRF3sf3HHxrxYl0e9pYhyPOpGvsbGmRLKBgkV9uZRV0ea0U=\" rel=\"nofollow\" target=\"_blank\">@ZymeworksInc<\/a>\u00a0on X.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>Investor Inquiries:<br \/>Shrinal Inamdar<br \/>Senior Director, Investor Relations<br \/>(604) 678-1388<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=P2vaiGdoGohGPBk9m-1fLnWssu2RkhRKfOCeRQxpGx8Srj3Tw2MyUwulyXcFn2LG72W7N1lFb9U2VxWJ0_EMig==\" rel=\"nofollow\" target=\"_blank\">ir@zymeworks.com<\/a>\u202f\u202f\u00a0<\/p>\n<p>Media Inquiries:<br \/>Diana Papove<br \/>Senior Director, Corporate Communications<br \/>(604) 678-1388<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2oHRPYwWSID6GIqi_cYJ_G8L-dg7z7FayNAO5rE4FLa9Jvr3w5H-ikywYJ9stdSodjk1isfFH5-iQN7ybmndyDcHLpOoEzVG-B0QjKbrSfI=\" rel=\"nofollow\" target=\"_blank\">media@zymeworks.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTgwOGJhMjAtODIwMS00ZTkxLWJiYTUtMWZmZDg5NmMzMDA0LTEyNjg0NDI=\/tiny\/Zymeworks-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will report its fourth quarter and full year 2024 financial results after market close on March 5, 2025. Following the announcement, management will host a conference call and webcast to discuss financial results and provide a corporate update on\u00a0March 5, 2025 at\u00a04:30 pm Eastern Time (ET). The event will be webcast live with dial-in details and webcast replays available on Zymeworks\u2019 website at https:\/\/ir.zymeworks.com\/events-and-presentations About Zymeworks Inc. Zymeworks\u00a0is a global clinical-stage biotechnology company committed to the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-812557","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will report its fourth quarter and full year 2024 financial results after market close on March 5, 2025. Following the announcement, management will host a conference call and webcast to discuss financial results and provide a corporate update on\u00a0March 5, 2025 at\u00a04:30 pm Eastern Time (ET). The event will be webcast live with dial-in details and webcast replays available on Zymeworks\u2019 website at https:\/\/ir.zymeworks.com\/events-and-presentations About Zymeworks Inc. Zymeworks\u00a0is a global clinical-stage biotechnology company committed to the &hellip; Continue reading &quot;Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-13T11:04:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025\",\"datePublished\":\"2025-02-13T11:04:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/\"},\"wordCount\":438,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/\",\"name\":\"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM=\",\"datePublished\":\"2025-02-13T11:04:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/","og_locale":"en_US","og_type":"article","og_title":"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025 - Market Newsdesk","og_description":"VANCOUVER, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will report its fourth quarter and full year 2024 financial results after market close on March 5, 2025. Following the announcement, management will host a conference call and webcast to discuss financial results and provide a corporate update on\u00a0March 5, 2025 at\u00a04:30 pm Eastern Time (ET). The event will be webcast live with dial-in details and webcast replays available on Zymeworks\u2019 website at https:\/\/ir.zymeworks.com\/events-and-presentations About Zymeworks Inc. Zymeworks\u00a0is a global clinical-stage biotechnology company committed to the &hellip; Continue reading \"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-13T11:04:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025","datePublished":"2025-02-13T11:04:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/"},"wordCount":438,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/","name":"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM=","datePublished":"2025-02-13T11:04:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzU2NSM2NzQ4NzExIzIyNTY4OTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-march-5-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and\u00a0Host Conference Call on March 5, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/812557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=812557"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/812557\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=812557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=812557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=812557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}